Akihide Yoshimi

Chief

National Cancer Center

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Akihide Yoshimi is a Chief at the National Cancer Center Japan. His research areas include multiple myeloma, hepatic gene expression, and immune checkpoint inhibitors in bladder cancer. His recent articles explore topics such as RNA splicing abnormalities in hematological malignancies and the impact of RNA-binding proteins in sarcomas. He is committed to advancing our understanding of cancer biology and therapeutic strategies.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Takaaki Yasuhara

Professor

Kyoto University

JAPAN

View details

Junko Mukohyama

Lecturer

International University of Health and Welfare Mita Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Akihide Yoshimi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Identification of a CD138-negative therapy-resistant subpopulation in multiple myeloma with vulnerability to splicing factor inhibition.

Concerted Actions of FoxO1 and PPARα in Hepatic Gene Expression and Metabolic Adaptation.

An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress

The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer

Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab

造血器腫瘍におけるRNAスプライシング異常

Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data.

Pathogenic Roles of RNA-Binding Proteins in Sarcomas

Structural basis of cytokine-mediated activation of ALK family receptors.

Aberrant RNA splicing and therapeutic opportunities in cancers.

Collaborators (2)

Takaaki Yasuhara

Junko Mukohyama

Make your next move.